Overview Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the clinical efficacy and safety of SK-0403 in patients with Type2 Diabetes Mellitus Phase: Phase 2 Details Lead Sponsor: Sanwa Kagaku Kenkyusho Co., Ltd.